Evidence map›Paper›PMID 42860517›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

PrOMet: Accurate and Robust Metal-Binding Site and Type Prediction.

Gangeun Park, Chaok Seok, Hahnbeom Park

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Gangeun ParkDepartment of Chemistry, Seoul National University, Republic of Korea.
Chaok SeokDepartment of Chemistry, Seoul National University, Republic of Korea.ORCID https://orcid.org/0000-0002-1419-9888
Hahnbeom ParkBiomedical Research Division, Korea Institute of Science and Technology, Seoul, Republic of Korea.ORCID https://orcid.org/0000-0002-7129-1912

Funding

Institute of Information & Communications Technology Planning & Evaluation RS-2025-25463302Korea Institute of Science and Technology 26Z9082Ministry of Health and Welfare RS-2024-00467483Ministry of Science and ICTNational Research Foundation of Korea RS-2024-00407331
6 · The paper itself

Abstract

Metal binding to proteins is crucial for many biological functions, yet the prediction of metal-binding sites and metal types remains underexplored compared to other biomolecular interactions. Despite advances in deep learning, computational methods have achieved limited success in this area; even the best-reported approaches reach only moderate localization accuracy on high-resolution crystal structures, and even worse when applied to medium-resolution data. We hypothesize that the main challenge lies in the nature of metal binding. While the putative sites span the entire protein surface, actual binding requires the atomic-level coordination geometry. We present a structure-based metal binding site and type predictor, PrOMet, in this work, which leverages a Prune-and-Optimization strategy built upon two hierarchically connected machine learning architectures. This strategy allows the method to effectively narrow the search space while maintaining robustness to AlphaFold models and medium-resolution cryo-EM structures. PrOMet outperforms existing methods, including structure-based and language model-based predictors, achieving a PR-AUC of 0.739 for metal ion localization and an average F1-score of 0.743 for metal type classification-Zn, Ca, Mg, Mn, Fe, Cu, respectively. PrOMet can be an effective tool for allocating uncertain metal positions and types within protein structures, as well as for metalloenzyme design studies.

Identifiers

PMID42860517
PMCPMC13654862

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.